Lisa Cabott Carson serves as Executive at Phio Pharmaceuticals Corp., where they oversee executive responsibilities. Since joining the company, Lisa Cabott Carson has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 5, 2026 involved receiving (via award) 47,000 shares valued at $0.
Lisa Cabott Carson currently holds 94,000 shares of Phio Pharmaceuticals Corp. (PHIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lisa Cabott Carson has been a net neutral trader of PHIO stock. They have purchased $0 and sold $0 worth of shares.
Lisa Cabott Carson's most recent insider trade was on Feb 5, 2026, when they sold 47,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |